Logo for LaunchBio Program: Larger than Life ScienceLogo for LaunchBio Program: Larger than Life Science

Building a strong network for life science innovators

  • October 16, 2025
  • 4-7:30pm PT
BioTerra, 5897 Oberlin Dr., San Diego

Roadmap to Investor Readiness

Practical strategies to align your financial plan with your science and investors

Register for the Event

Program

How do you design a financial roadmap that keeps your science moving forward while also satisfying investors? At this Larger Than Life Science event we will host a two-part program followed by a happy hour, networking, free professional headshots, and tours of Longellow’s brand-new BioTerra campus.


AGENDA:

4:00 – 4:30 PM | Registration & Welcome Reception

4:30 – 5:15 PM | Budgeting for Biotech: Building a Financial Roadmap That Matches Your Science

5:15 – 5:45 PM | Fireside Chat with Red Tree Venture Capital

5:45 – 7:30 PM |

  • Happy Hour with food & drinks provided
  • Free Professional Headshots (space is limited – please sign up when you arrive at the registration table)
  • Tours of BioTerra with Longfellow
  • Two Scientists Walk into a Bar – Kokila Shankar (Neuroscientists) and Steve Engleman (Environmental Engineering)

Free to attend. Space is limited — register today!

TALK

Budgeting for Biotech: Building a Financial Roadmap That Matches Your Science

Browne Consulting will lead a candid, interactive conversation on how early-stage life science companies can build and manage budgets that align with program goals and investors. Learn a practical framework to connect your financial strategy with your scientific goals. Browne will also share how to avoid common financial pitfalls.  Discussion moderated by: David Crean, Partner, 1004 Venture Partners

You’ll learn how to:

  • Break down R&D, G&A, and people costs
  • Use visual tools to track progress and communicate milestones
  • Adjust plans as your science evolves
  • Turn financial planning into a strategic advantage

SPEAKEr

  • David Crean, PhD

    David H. Crean, PhD, Partner, 1004 Venture Partners

    David H. Crean is a strategic financial advisor and venture investor with over 30 years of experience at the intersection of life sciences, healthcare technology, and investment banking. Based in San Diego, Dr. Crean is widely recognized for his expertise in driving business transformation, fostering innovation, and advancing investments in high-impact therapeutic areas, with a particular passion for neurodegeneration, cardiometabolic disease, oncology, and healthy aging. Dr. Crean currently serves as Venture Partner at 1004 Venture Partners, an emerging venture capital firm raising its inaugural fund of $100 million dedicated to building transformative companies that enhance healthy aging and longevity.

  • Warren Browne

    Warren Browne, MBA Founder & CEO, Browne Consulting

    Warren brings almost 20 years of Accounting, Finance, and HR experience to Browne Consulting. Since founding the company in 2016, he has led its growth to a 50 person firm, while supporting over 100 clients. Warren has consulted on dozens of venture backed companies from incorporation, advised companies as they grew through Series A, and supported companies going public or being acquired.

     

    Prior to Browne Consulting, Warren held CFO and Director of Finance positions at fast growing companies. In these roles, he oversaw all accounting, finance, and HR activity for the US entities. Previous to that, Warren worked in Controller and Manager roles in varying industries, serving in an operational accounting capacity.

Register for the Event

Fireside chat

Behind the Investment: Fireside Chat with Jeremy Caldwell, Red Tree Venture Capital

Budgeting is only half the equation; investors want to see how your numbers connect to real scientific impact. In this candid fireside chat, Jeremy Caldwell of Red Tree Venture Capital shares what sets Red Tree’s investment strategy apart, what types of biotech startups they’re backing right now, and how founders can position themselves for success in today’s evolving funding landscape.

Speaker

  • Jeremy Caldwell

    Jeremy Caldwell, PhD, Partner, Red Tree Venture Capital

    Dr. Caldwell is a partner at Red Tree Venture Capital. A widely respected executive and scientist with deep industry expertise built through a decorated career of industry and venture activities, Dr. Caldwell’s accomplishments span from creating innovative drug development companies to driving discovery, development and translation of novel therapies. He has forged deep ties to the San Diego and San Francisco Bay Area biotechnology communities, as well as far-reaching relationships within the global pharmaceutical space.Most recently Dr. Caldwell was CEO of Inception Therapeutics, Versant Ventures’ San Diego-based discovery engine for new company formation, a venture partner with Versant Ventures and a member of the firm’s investment team

Register for the Event

partners

Tags